Animal experiments have shown that tumor-derived factors such as IL-6, CXCL16, IFNγ, TNFα, and IGFBP-3 positively regulate the expression of CD38, and high expression of CD38 can enhance the immunosuppressive and tumor-promoting capacity of MDSCs (110). The gene discussed is CD38; the disease is neoplasm.